Posted in | News | Nanomaterials | Nanobusiness

Ceres Ventures Reveals Plans to Commercialize Nanotech-Based BluFlow Water Treatment System

Ceres Ventures has declared plans to accelerate the development and commercialization of its cutting-edge water and wastewater purification and treatment system called the BluFlow water treatment system, which integrates the company’s patent-pending nanotechnology and sophisticated ultra-purification technology to obtain clean water at a lower cost.

The BluFlow water treatment system is a first-of-its-kind single integrated system that enables highly efficient removal of specific targeted compounds, valuable elements, chemicals and pollutants from contaminated water and purification of up to 95% of treated water at lower operating, maintenance and energy costs than traditional water treatment systems.

The water treatment system comprises customizable nanoparticles that are specially designed to target and extract specific compounds or pollutants based on the quality of water being processed. It provides an economical solution to industrial water users to treat water, while reducing the consumption of freshwater in industrial processes. It enables natural chemical producers for pharmaceuticals, toiletries, cosmetics and food to reduce production costs and increase profit margins.

The BluFlow water treatment system is a suitable solution for thermoelectric power plants, which consume 201 billion gallons of water every day for cooling purposes. The system helps these facilities lower energy costs and freshwater consumption, which in turn reduces environmental impact.

Specific initiatives planned for the development and commercialization of the BluFlow water treatment system include:

  • Strengthening commercial protection through the filing of more patents
  • Scaling up existing working prototypes
  • Devising economical production techniques
  • Concluding a field ready second-generation BluFlow water treatment system prototype
  • Partnering with well-established engineering firms to instigate field testing and pre-sales initiatives
  • Producing and deploying initial BluFlow water treatment systems for field testing and market validation
  • Identifying commercial collaboration opportunities

Disclaimer: The views expressed here are those of the author expressed in their private capacity and do not necessarily represent the views of AZoM.com Limited T/A AZoNetwork the owner and operator of this website. This disclaimer forms part of the Terms and conditions of use of this website.

G.P. Thomas

Written by

G.P. Thomas

Gary graduated from the University of Manchester with a first-class honours degree in Geochemistry and a Masters in Earth Sciences. After working in the Australian mining industry, Gary decided to hang up his geology boots and turn his hand to writing. When he isn't developing topical and informative content, Gary can usually be found playing his beloved guitar, or watching Aston Villa FC snatch defeat from the jaws of victory.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Thomas, G.P.. (2019, February 12). Ceres Ventures Reveals Plans to Commercialize Nanotech-Based BluFlow Water Treatment System. AZoNano. Retrieved on November 21, 2024 from https://www.azonano.com/news.aspx?newsID=25259.

  • MLA

    Thomas, G.P.. "Ceres Ventures Reveals Plans to Commercialize Nanotech-Based BluFlow Water Treatment System". AZoNano. 21 November 2024. <https://www.azonano.com/news.aspx?newsID=25259>.

  • Chicago

    Thomas, G.P.. "Ceres Ventures Reveals Plans to Commercialize Nanotech-Based BluFlow Water Treatment System". AZoNano. https://www.azonano.com/news.aspx?newsID=25259. (accessed November 21, 2024).

  • Harvard

    Thomas, G.P.. 2019. Ceres Ventures Reveals Plans to Commercialize Nanotech-Based BluFlow Water Treatment System. AZoNano, viewed 21 November 2024, https://www.azonano.com/news.aspx?newsID=25259.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.